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Abstract
Skeletal muscle places a vital role in regulating immune function, glucose dis-
poser, protein synthesis, and mobility. This massive dynamic reservoir of proteins, 
minerals, and other metabolites could be cannibalized, and a loss of skeletal muscle 
may predispose impaired tissue hailing and few poor immune functions. Several 
studies had shown the reduced survival rates and the increased hospital lengths of 
stay of patients who have a poor nutrition status and low muscle mass. In addition, 
few studies have demonstrated the effect of muscle wasting on serum creatinine. 
There are no data available regarding its effect on serum creatinine, and moreover, 
ICU-acquired myopathy is rarely recognized because of insufficient diagnostic 
criteria or methodological limitations. Despite these limits, serum creatinine is still 
considered the standard for assessing acute changes in renal function. The present 
chapter details the existing evidence related to the effects of nutritional status and 
muscle wasting on serum creatinine based on recent evidences.
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1. Introduction
Skeletal muscle places a vital role in regulating immune function, glucose 
disposer, protein synthesis, and mobility. Unfortunately, critical illness is character-
ized by hypermetabolic and hypercatabolic states, which leads to an elevated resting 
energy expenditure rate, hyperglycaemia, altered substrate use, and increased 
oxygen consumption.
Among the patients who are previously well nourished before intensive care 
unit (ICU) admission, nutritional disorders develop rapidly because of the 
metabolic demands of illness, rapid fluid shifts, and the loss of specific vitamins 
and trace elements. Timely initiation of optimal nutritional support is important 
to slow the catabolic process and minimize adverse events such as prolonged 
mechanical ventilation, longer ICU stay, and increased risk of death [1]. The body’s 
reaction to the illness (trauma, burns, inflammation, or surgery) includes an 
increase of energetic metabolism, hypersecretion of counter-regulatory hormones 
(glucagon, glucocorticoids, and catecholamines), and release of inflammatory 
mediators and other hormonal mediators (vasopressin) in the general setting 
of inflammation. Protein energy malnutrition is associated with muscle weak-
ness, increased risk of infections, impaired wound healing, impaired coagulation 
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capacity, impaired gut function, reduced respiratory muscle function, and pro-
longed time to convalescence [2]. The present chapter details the existing evidence 
related to the effects of nutritional status and muscle wasting on serum creatinine 
(sCr) based on recent evidences.
1.1 Protein-energy nutritional status in intensive care
The assessment of caloric and protein requirements include clinical history, 
nutritional history, physical examination, laboratory test (like albumin, preal-
bumin, blood glucose, transferrin, and kidney and liver function), severity of 
the illness, body mass index (BMI), ideal body weight (IBW), resting energy 
expenditure (based on calorimetry), and protein requirements (based on nitro-
gen balance). The nutritional assessment could be performed by direct calo-
rimetry, performed by placing the patient in a calorimetric chamber, thermally 
insulated, in order to be able to evaluate the heat that it gives off by radiation, 
convection, conduction, and evaporation; this heat is detected by a water-cooled 
heat exchanger. Unfortunately, this method cannot be applied to all hospitalized 
patients. In critically ill, the gold standard is represented by indirect calorimetry, 
a method that measures respiratory gases: the oxygen of a determined volume of 
inspired air and the carbon dioxide produced. Therefore, numerous equations 
have been developed with the measurements performed with the indirect calo-
rimetry in mechanically ventilated patients (Table 1).
Such equations use dynamic physiological variables, which allow the recalcula-
tion of energy expenditure, in order to evaluate how much energy the body spends 
in the acute phase, and then, determine the minimum requests. Predictive equa-
tions are notoriously inaccurate for individual critically ill patients, due to large 
differences in disease-related metabolic rate, treatment, and interindividual factors. 
Many centers that do not have indirect calorimetry adopt a simple approach provid-
ing 25–30 kcal/kg/day. Guidelines of the European Society for Clinical Nutrition 
and Metabolism recommend an intake of 25 kcal/kg/day in critically ill patients, 
and for both females than for males, considering, however, a 10–20% increase in 
patients with SIRS and overweight (BMI > 25), considering the IBW for calculation 
of energetic requirements [3].
Formula Energetic requirements predicted (kcal/day) Mechanical 
ventilation
Harris-Benedict Man: 66 + (13.7 × BW) + (5 × H) − (6.8 × Age)
Woman: 65 + (9.6 × BW) + (1.7 × H) − (4.7 × Age)
No
Ireton-Jones (a) Mechanical Ventilation: 1925 − (10 × Age) + (5 × BW) +  
(281 × Sex) + (292 × Trauma) + (851 × Burn)
Spontaneous Breath: 629 − (11 × Age) + (25 × BW) +  
(689 × Obesity)
Yes
Frankenfield (b) 21,000 + (100 × RR) + (13 × Hb) + (300 × Sepsis) Yes
Swinamer (945 × BSA) - (6.4 × Age) + (108 × BT) + (24.2 × RR) +  
(817 × TV) - 4349
Yes
Faisy (8 × BW) + (15 × H) + (32 × RR) + (94 × BT) − 4834 Yes
BSA, Body surface area; BW, body weight; H, height; Hb, hemoglobin; RR, respiratory rate; BT, body temperature; 
and TV, tidal volume; (a) Sex, 1 = man, 0 = female; Trauma, 1 = present, 0 = absent; Burn, 1 = present, 0 = absent; 
and Obesity, 1 = present, 0 = absent. (b) Sepsis, 1 = present, 0 = absent, based on clinical evidence of presumed 
infection, systemic inflammation, or organ dysfunction.
Table 1. 
Predictive equations of energetic requirements (kcal/die) in critically ill patients.
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1.2 Muscle mass
Skeletal muscle has emerged as a potent regulator of immune system function in 
regulating immune function, glucose disposal, protein synthesis, and mobility [4]. 
Skeletal muscle can be viewed as the dynamic storage depot of amino acid, which 
is sensitive to the fed and fasted states but also of minerals and other intermediate 
metabolites [5], which can be depleted to meet the need for other tissues involved in 
the inflammatory response. The loss of skeletal muscle and reduced protein storage 
may predispose to a relative glutamine deficiency, which is seen as impaired tissue 
healing, poor immune function, and reduced survival [5]. Significant changes in 
body composition occur with aging and are a consequence of imbalances between 
energy intake and needs associated with an increasingly sedentary lifestyle [6].
1.3 Lean body mass
The body composition is often divided into fat mass and lean mass, the latter 
also known as lean body mass (LBM). LBM, unlike the fat mass that stores energy 
in the form of adipose tissue, includes muscle and visceral proteins and is mainly 
composed of water, proteins, glycogen, and minerals.
In pathological conditions such as chronic kidney disease (CKD), which is 
characterized by the presence of a positive water balance, it is necessary to perform 
an assessment of the volume of body water separately from the other components 
of the LBM. About half of LBM is made up of skeletal muscle mass, so the LBM 
compartment can be defined as heterogeneous and influenced by fluctuations in the 
distribution of water and electrolytes, which are more dynamic in nature in patients 
undergoing renal replacement therapy. Recent studies suggest that greater muscle 
mass is associated with greater longevity in people with chronic renal failure and 
in other chronic disease states [7]. Specific to LBM in the ICU, critically ill patients 
suffer significant LBM loss, much of it in the first 7–10 days of ICU stay [8]. However, 
patients gain weight back following ICU stay as fat mass but not as functional LBM 
[9]. Data in literature demonstrate that the catabolic/hypermetabolic state following 
injury can persist for up to 2 years following discharge from hospital, and this can 
markedly hinder the recovery of patients’ LBM and function following injury [9].
1.4 Serum creatinine
sCr is an endogenous substance generated by the nonenzymatic conversion of 
creatine and creatine phosphate, 95% of which is found in the muscles [10]. sCr is an 
uncharged, small molecular weight, unfilled substance (113 Da) which is not related 
to whey protein. It is filtered freely by the glomerulus without tubular resorption. 
sCr is also secreted by the kidney tubules only in small quantities. In clinical practice, 
levels of sCr are used to determine kidney function to estimate the glomerular filtra-
tion rate. Its rise usually indicates either acute kidney injury (AKI) or chronic kidney 
disease [11, 12]. Due to the correlation between sCr levels and muscle mass, sCr in the 
steady state has been used as a surrogate of muscle mass measurements [13].
Low sCr levels could be considered as a proxy of protein-energy wasting in some 
clinical situations [14]. Individuals’ sCr levels can be influenced by diet. In fact, 
arginine and glycine are precursors of creatine, and for this reason, a low protein 
intake in the diet can limit the generation of sCr. The sCr levels can be considerably 
lowered in the presence of protein malnutrition. Factors associated with low sCr 
levels are low muscle mass (female gender, elderly, and chronic illness), malnu-
trition, vegetarian diet, pregnancy, advanced liver disease, fluid overload, and 
augmented renal clearance.
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AKI is an event that commonly complicates the clinical course of critically ill 
patients, contributing to multi-organ failure and requiring appropriate nutritional 
interventions in a strategic treatment.
The metabolic and nutritional demands of AKI patients are affected not only from 
the uremic state but also from the underlying pathology and complications associated.
A personalized approach for each patient that involves an analysis of specific nutri-
tional requirements for each patient and a consideration of renal replacement therapy 
(RRT) support used is therefore necessary to improve the outcome of these patients.
Nitrogen is a fundamental component of the amino acids that make up the 
molecular structure of proteins. Proteins are the major functional substrate for cells 
and tissues and are essential for body growth and also for the maintenance and recov-
ery. Protein metabolism generates calories (about 4 kcal/g). Nitrogen is released from 
protein degradation, which is also lost from secretions or excreted in sweat, feces, and 
urine. In particular, urea nitrogen represents 85–90% of the urinary nitrogen loss.
In the ICU patient, the greater non-urinary loss occurs through the intestine, 
severe burns, RRT, and/or by abdominal drains. The nitrogen balance becomes 
negative (from −5 to −30 g day), reflecting the important protein catabolism.
The nitrogen balance is calculated as the difference between the nitrogen intake 
and output, according to the following equation:
 ( ) ( )N balance protein intake g / die / 6.25 urinary nitrogen g / die skin / stool lossesé ù é ù= - +ë û ë û  
where skin/fecal losses are approximately 2–4 g per day, while urinary losses can be 
recorded in the urine for 24 h (or by sampling for at least 4 h). The equivalence between 
urea in mmol/l and g occurs via two parameters: urea (g) = urea (mmol)/20.36, and 
then through the fact that 6.25 g of protein contains 1 g of nitrogen (Table 2).
In the setting of inflammatory state, acute loss of kidney homoeostatic function 
plays a central role in the worsening of the dysmetabolic state of the condition of 
critical illness. The stress response also induces changes in the use of substrates:
• Cellular insulin resistance acquired and secondary to the reduction of trans-
location of GLUT4 transporters on the plasma membrane, contributing to 
hyperglycaemia and alteration of cellular energy
Non-catabolic state Catabolic 
state
Proteins (g/kg/day) 0.8–1.0 (KDIGO 2012) Minimum 
1.0 (expert 
opinion)
Energy Energetic support is not influenced by AKI. Some authors suggested 20–30 kcal/
kg/day (KDIGO 2012). Others suggested 25–30 kcal/kg/day (Cano 2009, Brown 
2010, Gervisio 2011, McClave 2016)
Fluids Fluid balance and daily body weight must be monitored carefully. Fluid intake 
varies according with patient’s critical state, body weight, and fluid balance
Electrolytes Electrolytes should be monitored frequently and corrections vary according to the 
critical state and type of treatment
Micronutrients Evidences in this regard are scarce and not well documented. Usually, the levels 
of fat-soluble vitamins (Vit. A, Vit. D, Vit. E, Vit. K, and Vit. F) are low. CRRT 
has a negative effect on the balance of some vitamins and trace elements. It is not 
known whether micronutrient supplementation improves results
Table 2. 
Nutritional support in AKI patients.
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• Increased use of fatty acids as the use of glucose becomes inefficient
• Switch from protein anabolism to catabolism (net negative nitrogen balance)
2. Assessment of muscle mass and nutritional status in intensive care
Critically ill patients require a muscle mass assessment during their ICU stay. 
Unfortunately, the tools used to assess nutritional status are poor indicators of mal-
nutrition in the critically ill population. A sarcopenic obesity, characterized by excess 
fat and fluid retention of 10–20% of the patient’s body weight can mask the skeletal 
muscle wasting in the ICU [15]. Many ICU patients are edematous, and the measured 
weight, the BMI, and anthropometric measurements (mid-upper arm circumference 
and triceps skinfold thickness) may not reflect the real body muscle mass and could 
have limited results [16, 17]. In the ICU setting, albumin is also a poor marker of 
nutritional status not only due to changes in intravascular volume but also due to the 
impact of acute infection, inflammation, hepatic function, etc. [18]. Concerning the 
use of tools that assess muscle mass and nutrition, such as Nutrition Risk in Critically 
Ill Score [19], are difficult to perform and hence they cannot uniformly identify 
patients at risk of malnutrition. The bioelectrical impedance vector analysis is a useful 
method not only to evaluate tissue hydration but also to detect muscle mass variations 
in sarcopenic indictviduals, and it is able to discriminate sarcopenic individuals from 
sarcopenic obese individuals. However, the bioelectrical impedance vector analysis 
has some limitations: estimation of hydration status is related to fat-free mass, which 
basically means muscle mass (in the limbs). Whereas, the limbs contribute roughly 
90% to whole body impedance, only 6–12% are contributed by the trunk which, 
however, provides roughly 50% of the body weight and stores most of the surplus 
volume [20]. A baseline muscle mass assessment in the acutely critically ill patient is 
challenging. Muscle ultrasound is an attractive emerging technique able to offer quali-
tative analysis [21], inexpensive, and readily available at bedside. Unlike computed 
tomography (CT), however, international consensus does not exist on methodology, 
with significant differences between the techniques [21]. Although CT scans provide 
a reliable measure of muscle mass in these medically ill populations, CT scans are not 
performed on every critically ill patient due to cost and radiation exposure [22].
3. Muscle wasting and serum creatinine
After 10 days from the intensive care unit (ICU) admission [23, 24], a dynamic 
clinical state characterizes a “cascade” of new clinical problems [25]. This transition 
point is defined as “persistent critical illness” based on the point “beyond which 
diagnosis and severity of illness at admission are no more predictive of in-hospital 
mortality than are simple premorbid patient characteristics” [23]. Characterized by 
persistent inflammation, neurohumoral alterations, and prolonged immobilization, 
this catabolic state is not suppressed by nutrition [26, 27]. Catabolism results in 
muscle wasting and associated weakness, which impairs outcome [26–28]. Currently, 
there is no routine biomarker available with acceptable sensitivity and specificity 
which is able to monitor catabolism. Accurate monitoring of nitrogen losses and 
balances is not easy, but the presence and severity of catabolism often becomes 
clear once muscle loss and weakness are established. SCr is a metabolite of creatine 
phosphate, an energy store found in skeletal muscle, and in normal subjects it is pro-
duced at a constant rate. Particularly, a prolonged immobilization could decrease the 
plasma volume, bone mass, and skeletal muscle mass [29, 30]. A decrease in muscle 
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mass could theoretically be associated with changes in the metabolism of urea and 
sCr. Indeed, a muscle mass reduction could increase the urea generation because the 
muscular tissue has a high protein content and urea is the final catabolite of endog-
enous protein breakdown [31]. Disorders associated with dehydration/hypovolemia 
or with hypercatabolism increase plasma urea [32, 33]. In addition, skeletal muscle 
mass is the main determining factor of creatinine generation since creatinine is the 
final catabolite of muscle energy metabolism [34]. A decrease in muscle mass could 
decrease SCr levels, and conversely, SCr may be falsely increased with higher muscle 
mass. In addition, creatinine generation is low among individuals who have more 
diminutive muscle mass, either constitutionally or disease-related [13]. Due to the 
correlation between SCr levels and muscle mass, SCr in the steady state has been 
used as a surrogate of muscle mass measurements [35].
3.1 Muscle strength and sarcopenia index
Sarcopenia is a skeletal muscle disorder that is characterized by the loss of strength 
and mass together with impairment in physical function [36]. Sarcopenia is a complex 
syndrome that is associated with muscle mass loss, alone or in conjunction with 
increased fat mass. Since 2018, sarcopenia is not only considered as a debilitating 
condition that involves loss of muscle mass and function but also as a muscle disease. 
However, challenges in understanding the current evidence of the role of nutrition 
is represented by the number of different aspects of muscle health that have been 
considered as outcomes, both in observational and interventional study. New guide-
lines, which aim to improve consistency in the identification of sarcopenia in clinical 
care, identify muscle strength as the key characteristic of sarcopenia. This new 
guidance may also offer a useful structure within which to evaluate the influences on 
muscle health, including the effects of differences in diet [37]. Thus, a low muscle 
strength leads to a diagnosis of probable sarcopenia [37]. Sarcopenia is associated 
with frailty, poor surgical outcomes, prolonged need for mechanical ventilation, 
increased hospital cost, depression, decreased quality of life, increased risk of fall, 
nursing home residence, and a higher risk of death [38]. Evaluation of patients with 
sarcopenia could be really difficult as often physical function assessment is not 
performed and the measurement of muscle mass requires expensive and complex 
radiologic technique [39]. In addition, BMI, serum albumin levels, prealbumin levels, 
and physical examination lack in sensitivity and specificity to be used as surrogates 
for muscle mass. As previously reported, a low baseline sCr value is associated with a 
worse outcome and has been proposed as an indicator of low muscle mass [recently, a 
method to estimate muscle mass, named sarcopenia index (SI), was developed using 
the differential origin of two molecules cleared by the kidney: sCr (skeletal muscle 
cells) and cystatin C (nucleated cells) [40, 41], assuming steady kidney function]. 
The SI was calculated as (sCr value/cystatin C value) × 100. The SI not only signifi-
cantly correlates with imaging but also it has a superior performance compared with 
sCr alone in estimation of muscle mass, as reported by recent evidence [42].
3.2 Urea:creatinine ratio
The lack of validated and routinely available biomarkers of catabolism to some 
extent hampers the epidemiological and interventional studies on this topic. The initial 
decreases in sCr may be from altered metabolism and reflect bioenergetic failure. 
The subsequent continued fall in sCr reflected the length of ICU stay and length of 
hospitalization, and it is due to skeletal muscle loss (decreasing creatinine production) 
[43, 44]. Particularly, from 3 to 4 days after ICU admission, urea progressively rises, 
with a higher peak and greater duration of elevation in those patients remaining longer 
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in ICU. Recently, it was suggested that a persistent elevation in urea might reflect 
increased production from muscle catabolism, amino acid liberation, and metabo-
lism. Based on the observed trajectory of urea, this catabolic state appears to persist 
throughout ICU admission [27]. For this reason, elevated urea:creatinine (UCR) may 
reflect a combination of muscle bioenergetic failure, muscle catabolism/altered protein 
homeostasis, and persistent muscle wasting, providing a metabolic signature of the 
effects of prolonged critical illness [27, 45, 46]. Although the potential role of UCR in 
future studies, clinical usability seem limited, as other factors such as the following 
may increase UCR independent of catabolism: decreased effective blood volume, 
protein intake or gastrointestinal bleeding, and acute kidney injury (Figure 1).
Particularly, despite altered tubular reabsorption of urea (normally 40–50%) 
can affect the serum urea:creatinine, classically increased urea retention occurs dur-
ing severe dehydration with preserved tubular function. Conversely, tubular injury 
in AKI will lessen the concentrating capacity, thereby lessening urea:creatinine [47].
4. Conclusions
Critically ill patients suffer significant LBM loss, much of it in the first 7–10 days 
of ICU stay, requiring adequate timing initiation and optimal nutritional support 
to slow the catabolic process and to minimize adverse events such as prolonged 
mechanical ventilation, longer ICU stay, and increased risk of death. Due to the 
correlation between SCr levels and muscle mass, SCr in the steady state has been 
used as a surrogate of muscle mass measurements. However, SI could be consid-
ered a useful tool with a superior performance compared with sCr alone in the 
estimation of muscle mass, while the clinical usability of UCR seems limited and 
influenced by other factors such as decreased effective blood volume, protein intake 
or gastrointestinal bleeding, and also acute kidney injury. However, muscle wasting, 
often present in critically ill patients, can influence SCr and mask a diagnosis of 
AKI, decreasing the sensitivity of SCr for the early detection of AKI. Future studies 
should address the effect of muscle wasting on the true SCr concentration.
Figure 1. 
Urea:creatinine ratio in critical illness.
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